2021 Walk4MD Wrap-Up
Thanks to the dedicated teams and participants who registered and fundraised for The Tenaquip Foundation Walk4MD, as well as the amazing donors, sponsors, and research champions, this year’s event was a huge success!
As of today, Muscular Dystrophy Canada (MDC) has exceeded their fundraising goal and reached a total of $925, 158.28 with donations still coming in! The funds raised will be instrumental to delivering MDC’s basket of programs and services, funding life-changing equipment and technologies, investing in translational and clinical research, supporting next-generation clinicians and scientists, increasing education and awareness, influencing positive change, providing emotional support to those affected by NMD… and more.
This year, MDC focused their signature Walk event on research – in addition to a selected Research Champions Team, over 100 clinicians, researchers and students participated. The feedback from our community on the enhanced focus on research has been so positive.
If you missed the virtual event on Saturday, you can watch the replay here:
French: https://youtu.be/-cTGtzfMoT8
English: https://youtu.be/CWrInr5yL5g
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.